Strategic Health Group reports $3.1M surplus, defers GLP-1 policy decision
Strategic Health Group closes first half of FY26 with $3.1 million surplus. The board, chaired by Richard LaFond (Town of Webster), voted 8-0 to accept prior meeting minutes as consultant Ken Lombardi reported favorable claims data offsetting industry-wide pressures from major carriers' GLP-1 drug